United Therapeutics Corporation (UTHR): Price and Financial Metrics

UTHR POWR Grades

• Value is the dimension where UTHR ranks best; there it ranks ahead of 94.62% of US stocks.
• The strongest trend for UTHR is in Growth, which has been heading up over the past 179 days.
• UTHR ranks lowest in Momentum; there it ranks in the 16th percentile.

UTHR Stock Summary

• With a market capitalization of $10,206,910,547, UNITED THERAPEUTICS CORP has a greater market value than 84.26% of US stocks.
• With a price/sales ratio of 4.84, UNITED THERAPEUTICS CORP has a higher such ratio than 78.93% of stocks in our set.
• Equity multiplier, or assets relative to shareholders' equity, comes in at 1.25 for UNITED THERAPEUTICS CORP; that's greater than it is for just 15.22% of US stocks.
• Stocks that are quantitatively similar to UTHR, based on their financial statements, market capitalization, and price volatility, are ACLS, DAIO, TER, LQDT, and EGAN.
• UTHR's SEC filings can be seen here. And to visit UNITED THERAPEUTICS CORP's official web site, go to www.unither.com.

UTHR Valuation Summary

• In comparison to the median Healthcare stock, UTHR's price/sales ratio is 20% higher, now standing at 4.8.
• UTHR's price/earnings ratio has moved up 36.2 over the prior 243 months.

Below are key valuation metrics over time for UTHR.

UTHR Growth Metrics

The year over year net income to common stockholders growth rate now stands at 69.56%.
• Its 5 year net cashflow from operations growth rate is now at -15.12%.
• Its 2 year net income to common stockholders growth rate is now at 30.24%.

Over the past 67 months, UTHR's revenue has gone up $259,700,000.

The table below shows UTHR's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	1,860	848.9	707.4
2022-06-30	1,788.7	775.9	630.8
2022-03-31	1,768.3	797.1	687.4
2021-12-31	1,685.5	598.2	475.8
2021-09-30	1,655.2	549.8	462.4
2021-06-30	1,590.6	615.1	470.9

UTHR's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• UTHR has a Quality Grade of A, ranking ahead of 95.85% of graded US stocks.
• UTHR's asset turnover comes in at 0.344 -- ranking 133rd of 681 Pharmaceutical Products stocks.
• NEOG, AMGN, and AERI are the stocks whose asset turnover ratios are most correlated with UTHR.

The table below shows UTHR's key quality metrics over time.